General
Oxford University to launch trial alternating coronavirus vaccines from AstraZeneca and Pfizer-BioNTech
Oxford University says it will launch a trial alternating doses of COVID-19 vaccines created by different manufacturers.
Key points:
- The trial aims to determine whether different COVID-19 doses can be used interchangeably
- If successful, it could lead to a more flexible vaccine rollout, says the UK’s chief health officer
- Britain has been administering vaccines at an interval of 12 weeks to give more people a first dose, unlike other countries
The trial aims to determine whether different COVID-19 vaccine doses — those created by the AstraZeneca and Pfizer-BioNTech pharmaceutical companies — can be used interchangeably.
If successful it could allow greater flexibility in pressured vaccine delivery schedules.
The UK’s Deputy Chief Medical…
Continue Reading
-
Noosa News20 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business23 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News20 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
General7 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A